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Abstract 
   Bile duct ligation (BDL) is shown to induce cholestasis-related liver function impairments as well as 
consequent cognitive dysfunctions (i.e. impaired learning and memory formation). This study 
investigates the effects of cholestasis (14, 21 and 28 days post bile duct ligation) on spatial and non-
spatial novelty detection, using a non-associative task. Male mice weighing 30-35 g were used. 
Cholestasis was induced by ligation of the main bile duct using two ligatures and transecting the duct at 
the midpoint between them. Open field paradigm was employed to assess the spatial and non-spatial 
memories retention. Our data showed that cholestasis (28 days after bile duct ligation) decrease and 
increased duration time of displace and non-displace objects respectively, indicating spatial memory 
deficit. Moreover, this intervention (28 days after bile duct ligation) decreased and did not alter duration 
time of substitute and non-substitute objects respectively, suggesting non-spatial memory deficit. 
Moreover, the data postulated that 14 and 21 days post bile duct ligation both spatial and non-spatial 
memories did not alter. Our results suggested that cholestasis (28 but not 14 and 21 days post bile duct 
ligation) impaired spatial and non-spatial memory in the mice. 
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INTRODUCTION 
     Cholestasis is described by various degrees 
of symptoms mainly jaundice, pruritus, elevated 
serum levels of alkaline phosphatase, GGT (γ-
glutamyl transpeptidase), 5’-nucleotidase, bile 
acids, and cholesterol. Bile acid retention 
reduces new bile acid synthesis, which in turn 
results in decreased bile salt pool and 
dysregulation in the enterohepatic recirculation. 
There are several experimental models trying to 
elicit hepatic encephalopathy in lab animals [1]. 
The two of the most frequently used models are 
the administration of carbon tetrachloride, and 
the common bile duct ligation (BDL) [1]. 
Patients with liver diseases, also animal models 
of chronic liver failure [2] may show 
hypothermia as well as notable impairment in 
cognitive functions [3]. 
Acute or chronic liver failure may induce 
hepatic encephalopathy (HE), which may 
present a wide range of different grades from 
minimal HE to coma and death [2]. The 
disorder has been extensively studied using the 
model of common bile duct ligation in the 
rodents. In (BDL) model, the hepatocellular 
excretion of bile constituents is markedly 
impaired eliciting its retention within 
hepatocytes. Thus, accumulation of bile salts in 
the body and by deficiency of bile salts in the 
intestinal lumen causes cholestasis [4]. Several 
investigations indicated that HE induced several 
cognitive and non-cognitive symptoms such as 
the impairment of learning and memory [2, 3, 5, 
6] anxiolytic-like behaviors [7], alteration in 
sleep pattern [8] and tremor [9]. It has been 
reported that after HE, all classical 
neurotransmitter systems such as opioidergic, 
glutamatergic, GABAergic, cholinergic, 
serotoninergic can be altered [2, 5, 10-12]. A 
marked elevation of endogenous opioid levels in 
plasma of patients with cholestatic liver diseases 
and also with animal models of cholestasis have 
been shown [13]. Thus, there is suggestion that 
endogenous opioids are implicated in the 
pathophysiology of cholestasis [14, 15]. 
According to the above studies the aim of 
present study is investigation the effect of 
different days post BDL on spatial and non-
spatial memories.   
 
MATERIALS AND METHODS 
Animals 
     Subjects were male NMRI mice weighing 
30-35 g, bred at the Institute for Cognitive 
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Science Studies (ICSS), Tehran, Iran. Mice 
were kept in the animal house with a 12/12-h 
light-dark cycle and controlled temperature 
(22±2ºC). They were housed in groups of 10, in 
Plexiglas cages and had free access to food and 
water except during the limited periods of 
experiments. Eight animals were in each group 
and each animal was used once only. Behavioral 
experiments were done during the light phase of 
the light/dark cycle. All animal 
experimentations reported in this study, were 
conducted in accordance with the guidelines 
laid down by the NIH (NIH Guide for the Care 
and Use of Laboratory Animals) in the USA. 
The Research and Ethics Committee of the 
Faculty of Science of the University of Tehran 
approved the experimental protocol. 
Bile Duct Ligation surgery and induced 
cholestasis  
    There were three experimental groups: sham-
operated and bile duct ligated (BDL) mice. 
Mice receiving a BDL or sham-ligation surgery 
were anesthetized by an intraperitoneal injection 
of ketamine hydrochloride (50 mg/kg) plus 
xylazine (5 mg/kg). In mice receiving BDL, the 
common bile duct was located and ligated using 
4-0 silk at two points anterior to the pancreas 
and posterior to the hilum of the liver. One 
ligation was made just above the duodenum; the 
second ligation was made approximately 2 mm 
above the first ligation and then transected at the 
midpoint between the two ligatures [3, 16]. 
Sham-ligation surgery was performed by 
locating and manipulating the common bile 
duct. Sterile 0.9% NaCl solution (1mL/mice) 
was injected intraperitoneally immediately after 
the surgery. All surgeries were performed using 
aseptic technique. Immediately after the 
operation, each animal was placed in a cage by 
itself to prevent wound dehiscence and was 
moved to its original cage 4 h after the surgery 
[3, 7, 17]. Operative mortality was less than 
10%.  
Apparatus 
We used a circular open field apparatus (Borj 
Sanat Co, Tehran, Iran) as a spatial and non-
spatial learning and memory task. For his 
apparatus, there were minor modifications made 
in objects described in Roullet’s study [18]. 
Briefly, the task consisted of a metal circular 
box, 60 cm in diameter and 20 cm high. The 
arena’s ground area was divided into equal 
sectors. The wall of the arena was white, with a 
black striped pattern (1.5 cm thick line), 20 cm 
wide, 10 cm high. The six objects used in the 
open field were: A cube (a metal-plated 
parallelepiped, measuring 7×4×4 cm with 
irregular holes distributed on all sides), a cone (a 
plastic cone on a transparent cylinder base, 8 cm 
in diameter and 6 cm high), a ladder ( a small 
plastic white ladder, 5 cm wide and 16 cm high, 
having 10 steps connected to the two parallel 
arms, 3 cm thick), a cylinder ( a black 
cylinder,10 cm high and 4 cm in diameter, 
having a 2 cm in diameter hole on the top), a 
steel glass (12 cm high and 5 cm in diameter 
having a black handle) and a corner [this object 
consisted of two gray iron pieces (10 cm sides) 
with regularly pierced squares, forming a 90° 
angle, fixed on a quadrate 5 cm thick in sides. 
The corner object was used to examine the 
reactivity to non-spatial changes. 
Testing procedure and data collection 
Animals were placed into the empty open field 
for a 6 min period (session 1, S1). 5 min after 
S1 session, five successful sessions with 6 min 
period and 3 min interval were in the open field 
containing the objects. The animals were 
returned to their home cages immediately after 
each session. The objects were placed in a 
square configuration with a central object (cone) 
in sessions 2 to 4 (S2–S4). This configuration 
was changed by means of transposing the cone 
with the cylinder in session 5 (spatial change 
session, S5), in such a way that the initial square 
arrangement was changed (objects 
displacement). To measure the non-spatial 
memory, the glass object (as a familiar non-
displaced) was replaced by the corner as a new 
object, at the same location (object substitution, 
S6 session) [18-20]. 
The apparatus was illuminated using two red 
lights (80 W) fixed on the ceiling. The animal 
behaviors were recorded by a video camera 
while a monitor and a computer-recording 
system were installed in an adjacent room. The 
observed behaviors were manually recorded as 
raw data. The locomotor activity defined as 
mean sector crossings in all sessions (S1 to S6). 
Moreover, the time spent by the mouse in 
contact with an object (when the animal touched 
an object by its snout and made rearing against 
the object) was carefully recorded during S2-S6 
[18-20]. To measure the  spatial novelty 
detection, the mean time that mouse contacted 
with objects in S5 [both with displaced objects 
(DO) and non-displaced objects (NDO)] was 
subtracted from the mean time spent in contact 
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with the same object in S4. In addition, to 
measure the non-spatial novelty detection, the 
mean time that the animal contacted with 
objects in S6 [both substituted object (SO) and 
non-substituted object (NSO)] was deducted 
from the mean time spent in contact with the 
same object in S5. Experiments were carried out 
by someone blinded to doses of drugs and 
statistical measure. 
Drug treatment 
Four groups of mice were used in this 
experiment. Following S4, the spatial (S5-S4) 
and non-spatial (S6-S5) novelty detection were 
assessed in 24 h time, on the test day. The 
animals’ locomotor activities were recorded 
during S1 to S6. The data from cholestatic 
animals was compared with those from sham 
operated animals. 
Statistical analysis 
Given the normality of distribution and the 
homogeneity of the data variance, the results 
were statistically evaluated by one-way 
ANOVA repeated measures for the analysis of 
spatial and novelty. Further analyses for 
individual ‘between-group’ comparisons were 
carried out through post hoc Tukey’s test. In all 




   One-way ANOVA and post hoc Tukey’s 
analysis revealed that cholestasis decrease both 
spatial [displaced object-DO; F(3, 28)= 5.2, 
P<0.01, Fig.1B] and non-spatial novelty 
detection [substitute object-SO; F(3, 28)= 4.2, 
P<0.01, Fig.1C], while decreased non-displaced 
object-NDO [F(3, 28)= 9.1, P<0.001, Fig.1B]. 
The data showed that laparotomy did not alter 
locomotor activity [F(3, 28)= 3.12, P>0.05, 
Fig.1A] and  non-substituted object- NSO [F(3, 
28)= 1.02, P>0.05, Fig.1C]. In conclusion, the 
data showed that cholestasis (28 days post 




      The present data indicated that cholestasis 
impaired both spatial and non-spatial memories 
formation only 28 but not 14 and 21 days after 
BDL, meanwhile laparotomy did not alter 
locomotor activity in all memories testing days, 
suggesting the uniformity of data on memory 
formation. However the locomotor activity 
tends to decrease which was not significant. 
 
Figure.1. Effects of cholestasis on the time spent in 
contact with objects. Panel A: habituation profile in 
sessions 2–4. Panel B: reaction to object displacement is 
measured as time spent in contact with either displaced 
(DO) or non-displaced (NDO) objects in session 5 minus 
the same in session 4. Panel C: reaction to object 
substitution is measured as time spent in contact with 
either substituted (SO) or non-substituted (NSO) objects in 
session 6 minus the same in session 5. Each bar represents 
mean±S.E.M. **P <0.01 and +++P <0.001, as compared to 
sham-treated group.  
 
There are also reports showing that cognitive 
function and locomotor activity decreased 21 
days after BDL in the mice [5, 21]. If there is 
any controversy may be due to the method used, 
which may influence on the BDL response on 
locomotor activity.  
Cholestasis may result from various liver 
diseases. The impaired bile flow is secondary to 
structural or biochemical abnormalities of the 
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liver and/or the biliary tree. These alterations 
may be involved in: 1- rapid changes in 
transporter function, e.g. due to drug-induced 
direct inhibition of relevant transporters or 
changes in their localization; and 2- altered 
transporter expression, due to the inhibition of 
carrier synthesis or exacerbated degradation. As 
a consequence of the hepatocellular cholestasis, 
or blockade of intra- or extra-hepatic bile 
transit, the liver develops a number of 
secondary adaptive changes to minimize the 
detrimental effects of toxic biliary compounds 
retained as a consequence of the secretory 
failure. Although endogenous opioid peptide 
alterations under impaired bile secretion have 
been proven [22], the role of the opioid system 
in the regulation of hepato-biliary functions is 
yet not clear. 
As it has been indicated previously, BDL leads 
to biliary cirrhosis within 3 to 4 weeks [23], 
which occurs in conjunction with fibrosis, portal 
hypertension, portal-systemic shunting and 
immune system dysfunction [23-25]. 
Cholestasis-induced HE would correspond to 
type C [26] which associated with liver cirrhosis 
[27]. The liver cirrhosis in patients without 
clinical symptoms of HE may show mild 
cognitive impairment [28]. However, patients 
with manifestations of HE may present 
impairment of attention, memory and cognitive 
function, and also some alterations in motor 
function, including psychomotor slowing, 
bradykinesia or hypokinesia and asterixis. These 
behaviors in patients with cholestatic liver 
disease are central and not peripheral origin 
[29]. 
Some studies have shown an impaired ability to 
discriminate between the novel and the 
previously encountered sample objects [26] as 
well as impaired spatial memory acquisition in 
the Morris water maze task two to three weeks 
after BDL in cholestatic rodents [30]. There are 
other reports suggesting deficits in visuo-spatial 
abilities [31, 32] and working memory in 
patients with hepatic encephalopathy (HE) [33] 
which are suggested to be possibly due to the  
changes in the hippocampal formation [34].  
Based on the reports which indicate an increase 
in central opioidergic 
neurotransmission/neuromodulation tonus upon 
cholestasis, there is compelling evidence 
supporting the role of opioid system, 
accordingly. These include: 1- an opiate 
withdrawal-like reaction is seen upon opiate 
antagonist administration in cholestatic patients 
[35, 36] or experimental animals with 
cholestasis, 2- bile duct resection exhibit a state 
of antinociception which is reversed by 
naloxone [16]. HE is characterized by deficits in 
several neurotransmitter systems in the brain 
[37, 38] including opioidergic, dopaminergic, 
cholinergic, adrenergic, glutamatergic, 
GABAergic and serotoninergic [39]. 
Meanwhile, some other investigators have 
suggested that deficits in the release of 
corticotrophin-releasing hormone [29, 40, 41] 
and an imbalance in manganese homeostasis in 
the brain [42] are involved in cholestasis-
induced behaviors 
Given the three phases of memory formation 
process including acquisition, consolidation and 
retrieval, it is not yet fully understood whether 
this phenomenon is related to deficits in 
memory acquisition, consolidation and/or 
retrieval. In conclusion, our data indicated that 
cholestasis (28 days post BDL) impaired spatial 
and non-spatial memory in the open field task 
but other investigations are need to clearing 
involvement of different brain sites, 
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